These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

978 related articles for article (PubMed ID: 33560642)

  • 1. Nebulized Nitroglycerin for Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome: A Case Report.
    Daxon BT; Lark E; Matzek LJ; Fields AR; Haselton KJ
    A A Pract; 2021 Feb; 15(2):e01376. PubMed ID: 33560642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
    Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O
    Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhaled nitric oxide in COVID-19-induced ARDS - Is it worthwhile?
    Lotz C; Muellenbach RM; Meybohm P; Mutlak H; Lepper PM; Rolfes CB; Peivandi A; Stumpner J; Kredel M; Kranke P; Torje I; Reyher C
    Acta Anaesthesiol Scand; 2021 May; 65(5):629-632. PubMed ID: 33296498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Acute Respiratory Distress Syndrome and Pulmonary Embolism: A Case Report of Nebulized Nitroglycerin and Systemic Thrombolysis For Right Ventricular Failure.
    Karfunkle B; Gill J; Shirey S; Gordon R
    J Emerg Med; 2021 Nov; 61(5):e103-e107. PubMed ID: 34479748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled Nitric Oxide for Clinical Management of COVID-19: A Systematic Review and Meta-Analysis.
    Alqahtani JS; Aldhahir AM; Al Ghamdi SS; AlBahrani S; AlDraiwiesh IA; Alqarni AA; Latief K; Raya RP; Oyelade T
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Almitrine Infusion in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Acute Respiratory Distress Syndrome: A Single-Center Observational Study.
    Caplan M; Goutay J; Bignon A; Jaillette E; Favory R; Mathieu D; Parmentier-Decrucq E; Poissy J; Duburcq T;
    Crit Care Med; 2021 Feb; 49(2):e191-e198. PubMed ID: 33093279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia.
    Garfield B; McFadyen C; Briar C; Bleakley C; Vlachou A; Baldwin M; Lees N; Price S; Ledot S; McCabe C; Wort SJ; Patel BV; Price LC
    Br J Anaesth; 2021 Feb; 126(2):e72-e75. PubMed ID: 33288208
    [No Abstract]   [Full Text] [Related]  

  • 8. Nebulized Lidocaine in COVID-19, An Hypothesis.
    Ali ZA; El-Mallakh RS
    Med Hypotheses; 2020 Nov; 144():109947. PubMed ID: 32505070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome Subsets: Rationale and Clinical Applications.
    Redaelli S; Pozzi M; Giani M; Magliocca A; Fumagalli R; Foti G; Berra L; Rezoagli E
    J Aerosol Med Pulm Drug Deliv; 2023 Jun; 36(3):112-126. PubMed ID: 37083488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults.
    Gebistorf F; Karam O; Wetterslev J; Afshari A
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD002787. PubMed ID: 27347773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More questions than answers for the use of inhaled nitric oxide in COVID-19.
    Shei RJ; Baranauskas MN
    Nitric Oxide; 2022 Jul; 124():39-48. PubMed ID: 35526702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compassionate use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure due to COVID-19.
    Matthews L; Baker L; Ferrari M; Sanchez W; Pappachan J; Grocott MP; Dushianthan A;
    J Intensive Care Med; 2022 Aug; 37(8):1101-1111. PubMed ID: 35369798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulized activated protein C in a paediatric patient with severe acute respiratory distress syndrome secondary to H1N1 influenza.
    Pestaña D; de la Oliva P
    Br J Anaesth; 2011 Nov; 107(5):818-9. PubMed ID: 21997157
    [No Abstract]   [Full Text] [Related]  

  • 14. A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.
    Park E; You J
    J Korean Med Sci; 2022 Mar; 37(10):e82. PubMed ID: 35289141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of inhalation of nebulized nitroglycerin on dogs with experimental pulmonary hypertension induced by U46619.
    Gong F; Shiraishi H; Momoi MY
    Chin Med J (Engl); 2000 May; 113(5):475-6. PubMed ID: 11776110
    [No Abstract]   [Full Text] [Related]  

  • 16. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.
    Sinha P; Furfaro D; Cummings MJ; Abrams D; Delucchi K; Maddali MV; He J; Thompson A; Murn M; Fountain J; Rosen A; Robbins-Juarez SY; Adan MA; Satish T; Madhavan M; Gupta A; Lyashchenko AK; Agerstrand C; Yip NH; Burkart KM; Beitler JR; Baldwin MR; Calfee CS; Brodie D; O'Donnell MR
    Am J Respir Crit Care Med; 2021 Dec; 204(11):1274-1285. PubMed ID: 34543591
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhaled Nitric Oxide in Acute Severe Pulmonary Hypertension and Severe Acute Respiratory Distress Syndrome Secondary to COVID-19 Pneumonia: A Case Report.
    Vives M; Gascó I; Pla G; Maciel JL; Ricart Hernandez A; Regí Roman K; Parramon F
    Am J Case Rep; 2022 Oct; 23():e937147. PubMed ID: 36281210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rescue inhaled nitric oxide on right ventricle and pulmonary circulation in severe COVID-related acute respiratory distress syndrome.
    Bonizzoli M; Lazzeri C; Cianchi G; Guetti C; Fulceri GE; Socci F; Peris A
    J Crit Care; 2022 Dec; 72():153987. PubMed ID: 35120777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
    Ting CT; Chen BS
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
    Khiali S; Khani E; Entezari-Maleki T
    J Clin Pharmacol; 2020 Sep; 60(9):1131-1146. PubMed ID: 32557541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.